D Moradpour
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
Goossens N, Semmo N, Mullhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group. Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review. J Viral Hepat 2018; 25:920-929.
17.04.2018Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
17.04.2018J Viral Hepat 2018; 25:920-929
Goossens N, Semmo N, Mullhaupt B, Semela David, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L E, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group
Trends in hepatitis C-related mortality in Switzerland
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela D, Terziroli B, Bruggmann P, Moradpour D, Dufour J, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat 2017; 25:152-160.
20.11.2017Trends in hepatitis C-related mortality in Switzerland
20.11.2017J Viral Hepat 2017; 25:152-160
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela David, Terziroli B, Bruggmann P, Moradpour D, Dufour J-F, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort
Impact of common risk factors of fibrosis progression in chronic hepatitis C
Rüeger S, Halfon P, Bourlière M, Talal A, Jacobson I, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Argiro L, George J, Bochud P, Dufour J, Mullhaupt B, Semela D, Heim M, Moradpour D, Cerny A, Malinverni R, Booth D, Suppiah V, Negro F. Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut 2014
11.09.2014Impact of common risk factors of fibrosis progression in chronic hepatitis C
11.09.2014Gut 2014
Rüeger S, Halfon P, Bourlière M, Talal A H, Jacobson I M, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Argiro L, George J, Bochud P-Y, Dufour J-F, Mullhaupt B, Semela David, Heim M H, Moradpour D, Cerny A, Malinverni R, Booth D R, Suppiah V, Negro F
Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis
Moradpour D, Altorfer J, Flury R, Greminger P, Meyenberger C, Jost R, Schmid M. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology (Baltimore, Md.) 1994; 20:1437-41.
01.12.1994Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis
01.12.1994Hepatology (Baltimore, Md.) 1994; 20:1437-41
Moradpour D, Altorfer J, Flury R, Greminger Peter, Meyenberger Christa, Jost R, Schmid M